Generalist Bio Model Omnii-1 Beats AlphaGenome Across 8 Applications
anshulkundaje · x · 2026-10-21
The Omnii-1 team showcases 8 applications where a single generalist model outperforms specialized models across biological domains: it beats AlphaGenome on regulatory genomics benchmarks, generalizes to unseen modalities such as 5hmC for early cancer detection, and designs functional proteins, antibodies and personalized cancer vaccines.
Stanford epigeneticist Anshul Kundaje responded positively but recommended explicitly testing cell-type specificity of chromatin/expression prediction, noting most current models struggle with activity variation across cell contexts.
Related event: Omnii-1 launch: AI-designed phage given to human patient in world first(11 posts)→
More from Research
- AI agents with $10,000 budgets still fail open-ended research: GPT-6 Astra and Fable 5.1 papers rejected — sayashk · 2026-10-21
- Stanford team launches ScholarCatalyst, a benchmark for literature retrieval that inspires research — lateinteraction · 2026-10-21
- Simple symmetric Venn diagrams with 17, 19 and 23 curves found via AI-assisted search, verified in Lean 4 — pickover · 2026-10-21
- Pathway CEO in Forbes: Transformers Won't Get Us to Superintelligence, Experience-Learning AI Will — schwentker · 2026-10-21
- Laude Institute Backs Stanford's CLMs: Contrastive Language Models for Fast Decision-Making — Azaliamirh · 2026-10-21
- OpenAI acquires Orchestra Bio to bolster life sciences AI model Rosalind — TechCrunch AI · 2026-10-21